MolecuLight Inc

01/23/2024

Distribuidor oficial de en México y Latinoamérica.

12/25/2023

MolecuLight was just featured in a newly published paper, “An Open-Label, Proof-of-Concept Study Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients With Venous Leg Ulcers and Diabetic Foot Ulcers”. In the study, Bacterial load was reduced by 64% following treatment with EscharEx based on validation using a fluorescence imaging device (MolecuLight i:X). Publication: https://lnkd.in/dZYTRy-y Congratulations to the authors, incl Corrado Maria Durante Rob Snyder, DPM, MSc, MBA, CWSP, FFPM RCPS(Glasg)

12/15/2023

To all our amazing customers around the world -- Happy and Healthy Holiday Season from MolecuLight Inc and wishing you a restful break. Thank you for all the healing you enable during the year. May it be a time for (wound) healing. In lieu of gifts, we have made a donation to the Daily Bread Food Bank

12/12/2023

Press Release: MolecuLight Inc Successfully Completes SOC 2 Type II Audit. The company's compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security

The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security TORONTO, ON – (December 12, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial l...

12/06/2023

See MolecuLight Inc featured in the latest “Is your wound bioburdened” in Today's Wound Clinic : “We have been utilizing MolecuLight during every visit to help guide our decision-making with real-time evidence. The availability of taking post-intervention pictures or videos with MolecuLight allows us to evaluate our approach and ensure the wounds are free of elevated bacterial burden…” Ali Saberi MD, Heal Precisely https://lnkd.in/guw4hwFP

11/21/2023

PRESS RELEASE: United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical’s Patent. MolecuLight Inc Victorious in its Efforts to Prove Swift Medical Did Not Merit a Patent https://tinyurl.com/2p8naafn

11/20/2023

Hear Joe McClung (FloodGate Medical) profile MolecuLight Inc and Martha Yannessa in his SAWC Symposium on Advanced Wound Care (SAWC) Fall 2023 Buzz Report

0:00 Introduction0:24 Kristen Membrino | AVP of Sales at HMP Global1:47 Brian Grow | CCO of Organogenesis2:18 Martha Yannessa | EVP of Moleculight3:14 Chris ...

11/20/2023

Submit your abstract for for (European Wound Management Association) 2024 showing the utility and clinical outcomes with your MolecuLight Inc device -- and present your work at Europe's largest wound care conference. Abstract submission deadline is 6 December, 2023 at 23:59 CET https://tinyurl.com/3khju8r7

11/09/2023

Looking for Reimbursement information on fluorescence imaging (MolecuLight Inc ) for detection of elevated bacterial burden presence, location and load? Check out Today's Wound Clinic ’s Wound Clinic “Reimbursement Library” https://www.hmpgloballearningnetwork.com/site/twc/reimbursement-z

11/07/2023

Watch reimbursement expert Kathleen D. Schaum sharing her insights about HOPD coding and Medicare payment for the MolecuLight Inc procedure for real-time fluorescence wound imaging for bacterial presence, location, and load in wounds. This 25 minute video is suggested for wound care clinicians, coders and billers who are interested in the reimbursement pathway for the MolecuLight procedure in a HOPD setting

Watch reimbursement expert Kathleen D. Schaum, MS, President of Kathleen D. Schaum & Associates, Inc share her insights about HOPD coding and Medicare paymen...